Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors

Table 1 Prostate cancer surveillance guideline [10, 42]

Surveillance	Year 1	Year 2–3	Year 4–10
Office visits	3, 6, and 12 months	Every 6 months	Annually
PSA monitoring	3, 6, and 12 months	Every 6 months	Annually
Physical examination	Only if indicated	Only if indicated	Only if indicated

ISSN: 1471-2407